LD
Li Dean Y Executive VP & President, MRL
OFFICER M
US US · SEC (Form 4)
Browse the full record of transactions filed by Li Dean Y, Executive VP & President, MRL. Director active across 2 companies, notably Merck & Co., Inc.. Cumulatively, 21 disclosures have been published. Total volume traded: €938k. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 21 total
018,145 shares 0
Class A Common Stock
SEC:0001209191-22-037640:0 · 14 Jun 2022
€64,352 773 shares @ €83.25 0.0000% mcap 12.4% of flow
Common Stock
SEC:0001127602-22-013279:0 · 3 May 2022
€89,313 1,061 shares @ €84.1783 0.0000% mcap 17.2% of flow
Common Stock
SEC:0001127602-22-013028:0 · 1 May 2022
01,544 shares 0
Class A Common Stock
SEC:0001209191-22-023302:0 · 1 Apr 2022
€196,556 3,023 shares @ €65.0203 0.0001% mcap 37.8% of flow
Common Stock
SEC:0001127602-22-007019:0 · 24 Feb 2022
0659 shares 0
Class A Common Stock
SEC:0001209191-22-002060 · 3 Jan 2022
0659 shares 0
Class A Common Stock
SEC:0001209191-22-002060:0 · 3 Jan 2022
€269,851 14,900 shares @ €18.1108 57.5% of flow
Class A Common Stock
SEC:0001209191-21-068918 · 7 Dec 2021
€99,580 5,626 shares @ €17.6999 21.2% of flow
Class A Common Stock
SEC:0001209191-21-068911 · 17 Nov 2021
€99,580 5,626 shares @ €17.6999 0.0046% mcap 10.6% of flow
Class A Common Stock
SEC:0001209191-21-068911:0 · 17 Nov 2021
€269,851 14,900 shares @ €18.1108 0.012% mcap 28.8% of flow
Class A Common Stock
SEC:0001209191-21-068918:0 · 7 Dec 2021
€99,580 5,626 shares @ €17.6999 21.2% of flow
Class A Common Stock
SEC:0001209191-21-065896 · 17 Nov 2021
€99,580 5,626 shares @ €17.6999 0.0046% mcap 10.6% of flow
Class A Common Stock
SEC:0001209191-21-065896:0 · 17 Nov 2021
0543 shares 0
Class A Common Stock
SEC:0001209191-21-059736 · 1 Oct 2021
0543 shares 0
Class A Common Stock
SEC:0001209191-21-059736:0 · 1 Oct 2021
0330 shares 0
Class A Common Stock
SEC:0001209191-21-045552 · 1 Jul 2021
0330 shares 0
Class A Common Stock
SEC:0001209191-21-045552:0 · 1 Jul 2021
694 shares
Common Stock
SEC:0001127602-21-015763 · 4 May 2021
€43,887 694 shares @ €63.2374 0.0000% mcap 8.4% of flow
Common Stock
SEC:0001127602-21-015763:0 · 4 May 2021
€63,276 1,030 shares @ €61.4327 0.0000% mcap 100.0% of flow
Common Stock
SEC:0001127602-21-015262 · 1 May 2021
€63,276 1,030 shares @ €61.4327 0.0000% mcap 12.2% of flow
Common Stock
SEC:0001127602-21-015262:0 · 1 May 2021
About Li Dean Y Li Dean Y is the Executive Vice President and President of MRL at Merck & Co., Inc.